India to United Arab Emirates: Fluticasone Export Trade Route
India has recorded 337 verified shipments of Fluticasone exported to United Arab Emirates, representing a combined trade value of $5.4M USD. This corridor is served by 21 active Indian exporters, with an average shipment value of $16.0K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 78% of total export value with 25 shipments worth $4.2M USD. On the buying side, MEDA PHARMACEUTICALS is the largest importer in United Arab Emirates with $1.6M USD in purchases. The top 3 suppliers — CIPLA LIMITED, VAMSI PHARMA PRIVATE LIMITED, ANR HEALTH CARE PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Arab Emirates Fluticasone corridor is one of India's established pharmaceutical export routes, with 337 shipments documented worth a combined $5.4M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's fluticasone manufacturing sector.
Across 21 active suppliers, the average shipment value stands at $16.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 29.0%, placing it at rank #3 among India's top fluticasone export destinations globally.
On the import side, key buyers of Indian fluticasone in United Arab Emirates include MEDA PHARMACEUTICALS, MEDA PHARMACEUTICALS MEA FZ LLC CODSV SOLUTIONS FZE, ACINO PHARMACEUTICALS FZ LLC and 22 others. MEDA PHARMACEUTICALS is the single largest importer with 8 shipments valued at $1.6M USD.
Route Characteristics
- Average transit32 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#3
- Annual growth+29.0%
- Demand growth+24.3%
- Regulatory ease65/100
Top 10 Indian Fluticasone Exporters to United Arab Emirates
Showing top 10 of 21 Indian suppliers exporting Fluticasone to United Arab Emirates, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $168.6K per shipment | 25 | $4.2M | 78.2% |
| 2 | VAMSI PHARMA PRIVATE LIMITED Avg $62.3K per shipment | 17 | $1.1M | 19.7% |
| 3 | ANR HEALTH CARE PRIVATE LIMITED Avg $2.8K per shipment | 11 | $31.2K | 0.6% |
| 4 | SWETA DISTRIBUTORS PRIVATE LIMITED Avg $9.5K per shipment | 3 | $28.5K | 0.5% |
| 5 | ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED Avg $20.6K per shipment | 1 | $20.6K | 0.4% |
| 6 | GAIA TRADE PRIVATE LIMITED Avg $54 per shipment | 240 | $12.9K | 0.2% |
| 7 | GLENMARK PHARMACEUTICALS LIMITED Avg $5.4K per shipment | 2 | $10.9K | 0.2% |
| 8 | RESPIPURE PHARMA PRIVATE LIMITED Avg $1.7K per shipment | 2 | $3.5K | 0.1% |
| 9 | ZIL PHARMA Avg $447 per shipment | 5 | $2.2K | 0.0% |
| 10 | HUMANKIND PHARMA Avg $369 per shipment | 5 | $1.8K | 0.0% |
This table shows the top 10 of 21 Indian companies exporting fluticasone to United Arab Emirates, ranked by total trade value. The listed exporters are: CIPLA LIMITED, VAMSI PHARMA PRIVATE LIMITED, ANR HEALTH CARE PRIVATE LIMITED, SWETA DISTRIBUTORS PRIVATE LIMITED, ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, GAIA TRADE PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LIMITED, RESPIPURE PHARMA PRIVATE LIMITED, ZIL PHARMA, HUMANKIND PHARMA. CIPLA LIMITED is the dominant supplier with 25 shipments worth $4.2M USD, giving it a 78% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Showing top 10 of 21 total Indian exporters on the India to United Arab Emirates Fluticasone export route.
Top 10 Fluticasone Importers in United Arab Emirates
Showing top 10 of 25 known buyers in United Arab Emirates receiving Fluticasone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fluticasone in United Arab Emirates include MEDA PHARMACEUTICALS, MEDA PHARMACEUTICALS MEA FZ LLC CODSV SOLUTIONS FZE, ACINO PHARMACEUTICALS FZ LLC, M/S.INTAPHARM LABORATORIES FZCO, PHARMAX PHARMACEUTICALS FZ LLC, among 25 total buyers. The largest importer is MEDA PHARMACEUTICALS, accounting for $1.6M USD across 8 shipments — representing 30% of all fluticasone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDA PHARMACEUTICALS | 8 | $1.6M | 30.3% |
| 2 | MEDA PHARMACEUTICALS MEA FZ LLC CODSV SOLUTIONS FZE | 6 | $1.2M | 22.3% |
| 3 | ACINO PHARMACEUTICALS FZ LLC | 7 | $839.5K | 15.6% |
| 4 | M/S.INTAPHARM LABORATORIES FZCO | 13 | $742.9K | 13.8% |
| 5 | PHARMAX PHARMACEUTICALS FZ LLC | 3 | $341.6K | 6.3% |
| 6 | M S INTAPHARM LABORATORIES FZCO | 2 | $217.1K | 4.0% |
| 7 | MEDA PHARMACEUTICALS ALI FREE ZONE DUBAI UAE DUBAI | 1 | $199.7K | 3.7% |
| 8 | M/S.INTAPHARMA LABORATORIES FZCO | 2 | $99.6K | 1.8% |
| 9 | HEALTHDECK DRUG STORE LLC | 3 | $28.5K | 0.5% |
| 10 | DAWAA DRUG STORE LLC | 10 | $25.2K | 0.5% |
Showing top 10 of 25 Fluticasone importers in United Arab Emirates on this route.
Top 10 Fluticasone Formulations Imported by United Arab Emirates
Showing top 10 of 94 product formulations shipped on the India to United Arab Emirates Fluticasone route, ranked by trade value
United Arab Emirates imports a wide range of fluticasone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DYMISTA TRADE PACK 17ML/120 MD (AZELASTINE HYDROCHLORIDE 137 MCG AND FLUTICASONEPROPIONATE 50 MCG NASAL SUSPENSION) DYM — accounts for $1.0M USD across 5 shipments. There are 94 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DYMISTA TRADE PACK 17ML/120 MD (AZELASTINE HYDROCHLORIDE 137 MCG AND FLUTICASONEPROPIONATE 50 MCG NASAL SUSPENSION) DYM | 5 | $1.0M | 18.9% |
| 2 | DYMISTA TRADE PACK 17ML/120MD AZELASTINE HYDROCHLORIDE 137 MCG AND FLUTICASONEPROPIONATE 50MCG NASAL SUSPENSION DYMIS | 4 | $801.7K | 14.9% |
| 3 | DYMISTA TRADE PACK 17ML/120 MD (AZELASTINE HYDROCHLORIDE 137 MCG ANDFLUTICASONE PROPIONATE 50 MCG NASAL SUSP | 3 | $617.0K | 11.4% |
| 4 | DYMISTA TRADE PACK 17ML/120 MDAZELASTINE HYDROCHLORIDE 137 MCG AND FLUTICASONEPROPIONATE 50 MCG NASAL SUSPENSIONDYMI | 2 | $398.2K | 7.4% |
| 5 | FLUTICASONE (500MCG) & SALMETEROL (50 MCG)INHALATION POWDER (12.5 MG) | 3 | $371.8K | 6.9% |
| 6 | SEROFLO 250 MCG INHALER (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 250 MCG)NOS | 2 | $353.7K | 6.6% |
| 7 | DYMISTA TRADE PACK 17ML/120 MD AZELASTINE HYDROCHLORIDE 137 MCG AND FLUTICASONEPROPIONATE 50 MCG NASAL SUSPENSION DYM | 1 | $199.7K | 3.7% |
| 8 | FLUTICASONE (250MCG) & SALMETEROL (50 MCG)INHALATION POWDER (12.5 MG) | 3 | $195.4K | 3.6% |
| 9 | FLUTICASONE (500MCG) & SALMETEROL (50MCG) INHALATION POWDER (12.5MG) | 4 | $190.4K | 3.5% |
| 10 | SEROFLO 250 MCG INHALER SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 250 MCG | 1 | $188.4K | 3.5% |
Showing top 10 of 94 Fluticasone formulations imported by United Arab Emirates on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 157 shipments. Transit time averages 32 days by sea.
Market Dynamics
India's fluticasone exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 25 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, VAMSI PHARMA PRIVATE LIMITED, ANR HEALTH CARE PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $16.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as dymista trade pack 17ml/120md azelastine hydrochloride 137 mcg and fluticasonepropionate 50mcg nasal suspension dymis and dymista trade pack 17ml/120 md (azelastine hydrochloride 137 mcg andfluticasone propionate 50 mcg nasal susp, suggesting that buyers in United Arab Emirates tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MEDA PHARMACEUTICALS is the largest importer with 8 shipments worth $1.6M USD — representing 30% of all fluticasone imports from India on this route. A total of 25 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $5.4M
- Avg. Shipment
- $16.0K
- Suppliers
- 21
- Buyers
- 25
- Transit (Sea)
- ~32 days
- Annual Growth
- +29.0%
Related Analysis
Other Fluticasone Routes
Unlock the Full India to United Arab Emirates Fluticasone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 337 shipments on this route.
Frequently Asked Questions — India to United Arab Emirates Fluticasone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fluticasone to United Arab Emirates?
The leading Indian exporters of Fluticasone to United Arab Emirates are CIPLA LIMITED, VAMSI PHARMA PRIVATE LIMITED, ANR HEALTH CARE PRIVATE LIMITED. CIPLA LIMITED holds the largest market share at approximately 78% of total trade value on this route.
Q What is the total value of Fluticasone exports from India to United Arab Emirates?
India exports Fluticasone to United Arab Emirates worth approximately $5.4M USD across 337 recorded shipments. The average value per shipment is $16.0K USD.
Q Which ports does India use to ship Fluticasone to United Arab Emirates?
The most active port of origin is SAHAR AIR with 157 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to United Arab Emirates for Fluticasone?
The average transit time for Fluticasone shipments from India to United Arab Emirates is approximately 32 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United Arab Emirates Fluticasone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.0% with demand growth tracking at 24.3%. The route is ranked #3 among India's top Fluticasone export destinations globally.
Q How many suppliers are active on the India to United Arab Emirates Fluticasone route?
There are currently 21 active Indian suppliers exporting Fluticasone to United Arab Emirates. The market is moderately concentrated with CIPLA LIMITED accounting for 78% of total shipment value.
Q Who are the main importers of Fluticasone from India in United Arab Emirates?
The leading importers of Indian Fluticasone in United Arab Emirates include MEDA PHARMACEUTICALS, MEDA PHARMACEUTICALS MEA FZ LLC CODSV SOLUTIONS FZE, ACINO PHARMACEUTICALS FZ LLC, M/S.INTAPHARM LABORATORIES FZCO, PHARMAX PHARMACEUTICALS FZ LLC. MEDA PHARMACEUTICALS is the largest buyer with 8 shipments worth $1.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Arab Emirates export trade corridor identified from Indian Customs (DGFT) records for Fluticasone.
- 2.Supplier/Buyer Matching: 21 Indian exporters and 25 importers in United Arab Emirates matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 337 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
337 Verified Shipments
21 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists